Royce & Associates’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVNS
Royce & Associates's AVNS Position: Q3 2026 in Review
Royce & Associates sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 60,703 shares — an estimated $1.51M sold.
Royce & Associates first reported a position in AVNS in Q3 2015 and held it in 5 quarters. The position peaked at $7.2M in Q1 2026. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.
- Royce & Associates reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
- Royce & Associates sold 60,703 Avanos Medical shares in Q3 2026, an estimated $1.51M.
- Royce & Associates first reported a position in Avanos Medical in Q3 2015 and held it in 5 quarters.
- Royce & Associates's Avanos Medical position peaked at $7.2M in Q1 2026.
- 3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.
Based on Royce & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.